Christina Zjukovskaja
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Climate change impacts the symptomology and healthcare of multiple sclerosis patients through fatigue and heat sensitivity - A systematic review.
Journal: Journal of the neurological sciences
Published: December 27, 2024
Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: November 22, 2024
BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis.
Journal: Bone marrow transplantation
Published: March 12, 2024
Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantation.
Journal: Multiple sclerosis and related disorders
Published: January 09, 2024
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 22, 2023
CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: December 23, 2022
Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis.
Journal: Brain communications
Published: July 08, 2022
Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: June 20, 2022
Distribution of five clinically important neuroglial proteins in the human brain.
Journal: Molecular brain
Published: January 11, 2022
Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: January 05, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026